direct bilirubin

Bilirubin is produced from heme breakdown (primarily from senescent RBCs via macrophages in the spleen/liver, releasing heme which is converted to biliverdin then unconjugated bilirubin). Unconjugated (indirect) bilirubin is lipid-soluble, bound to albumin in blood, and taken up by hepatocytes where UGT1A1 conjugates it with glucuronic acid to form direct (conjugated) bilirubin, which is water-soluble and excreted into bile canaliculi via MRP2 transporters, then into the intestine.

Clinically, direct bilirubin elevation (conjugated hyperbilirubinemia) suggests: - Hepatocellular disease (hepatitis, cirrhosis) with impaired excretion - Cholestasis (intrahepatic or extrahepatic obstruction - gallstones, pancreatic head cancer, cholangiocarcinoma, PBC, PSC) - Dubin-Johnson syndrome (defective MRP2 canalicular transport, benign, black liver) - Rotor syndrome (defective hepatic storage, benign)

This contrasts with indirect (unconjugated) hyperbilirubinemia seen in hemolysis, Gilbert syndrome (reduced UGT1A1 activity), and Crigler-Najjar syndrome (absent/deficient UGT1A1).

Key diagnostic significance: Direct bilirubin is water-soluble, so it appears in urine (bilirubinuria) when elevated, causing dark/tea-colored urine—a hallmark of obstructive/hepatocellular jaundice, absent in pure hemolytic (indirect) hyperbilirubinemia. Direct bilirubin >50% of total bilirubin suggests conjugated hyperbilirubinemia requiring workup for biliary obstruction or hepatocellular injury (via liver function tests, imaging like RUQ ultrasound, and further workup as needed).

Lab interpretation: Total bilirubin = direct + indirect. Elevated direct with normal indirect = pure conjugated hyperbilirubinemia (obstruction/cholestasis). Elevated indirect with normal direct = hemolysis or conjugation defects (Gilbert, Crigler-Najjar). Mixed elevation often seen in hepatocellular disease.